We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
| Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
|---|---|---|---|---|---|
| Ikigai Ventures Limited | LSE:IKIV | London | Ordinary Share | GG00BPG8J619 | ORD NPV |
| Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|---|---|
| 0.00 | 0.00% | 46.50 | 45.00 | 48.00 | 46.50 | 46.50 | 46.50 | 0.00 | 08:00:00 |
| Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
|---|---|---|---|---|---|
| Investors, Nec | 0 | -642k | -0.0310 | -15.00 | 9.62M |
From Apr 2022 to Apr 2024
TIDMIKIV
RNS Number : 6379U
Ikigai Ventures Limited
29 March 2023
29 March 2023
IKIGAI VENTURES LIMITED
(" Ikigai " or the " Company ")
Unaudited Interim Results
Ikigai, (LON:IKIV) an investment company established to acquire businesses focused on having a strong positive social impact , announces its unaudited interim results for the six months ended 31 December 2022.
For further information please contact:
Ikigai Ventures Limited Via IFC Nick Bryan-Brown, CEO Cosign Limited (Company Secretary) +44 (0)1481 211 000 Amit Taylor Strand Hanson Limited (Financial Advisor) Rory Murphy / Abigail Wennington +44 (0) 207 409 3494 Novum Securities (Broker) Colin Rowbury +44 (0) 207 399 9400 IFC Advisory Limited (Financial PR and IR) +44 (0) 203 934 6630 Tim Metcalfe Zach Cohen
DIRECTORS' REPORT
FOR THE SIX MONTH PERIOD FROM 01 JULY 2022 TO 31 DECEMBER 2022
The directors submit the half year report and unaudited financial statements of Ikigai Ventures Limited (the "Company") which is incorporated in Guernsey, for the six month period ended 31 December 2022.
PRINCIPAL ACTIVITY
The principal activity of the Company is that of an investment company established to acquire businesses focused on having a strong positive social impact. There has been no change in the activity of the Company during the period.
PUBLIC LISTING
During the period the company was admitted to the main market for listed securities of the London Stock Exchange under the ticker symbol "IKIV" with shares registered with an ISIN of GG00BPG8J619 and SEDOL of BPG8J61. The Company issued 4,180,000 Ordinary Shares on admission raising GBP2,090,000 to pursue the Company's strategy through paying the costs of admission, the costs of due diligence associated with a potential acquisition and to pay towards the costs of re-admission on an acquisition.
BUSINESS UPDATE
Since its listing, the Company has actively sought potential international acquisition targets both in Asia and in Europe. Companies operating in a range of sectors have been reviewed and early stage discussions have been held with a number of them, including businesses operating in the energy transition, waste recycling and surgical devices sectors.
Financial and equity market conditions remain challenging and the Company has continued to take soundings from the investment community in order to match investor appetite with the opportunities available.
Our investment focus remains relatively wide within the broader ESG market segment and we will continue to seek out and develop attractive potential acquisition targets and will provide further information to shareholders when appropriate.
DIVIDS
The directors do not recommend the payment of a dividend.
RESULTS
The results of the Company for the six month period ended 31 December 2022 are shown in the Statement of Comprehensive Income.
RISK FACTORS
Market conditions
Current volatile financial and equity market conditions represent a potential threat to the ability of the Company to complete the acquisition of a suitable target company and secure readmission.
Challenges in acquiring a suitable target
The Company's strategy and future success is dependent to a significant extent on its ability to identify a suitable acquisition opportunity and to execute a reverse takeover of the chosen acquisition target on attractive terms consistent with the Company's strategy. The Company cannot currently predict the period of time it will take to identify a suitable acquisition. If a target is not identified within 18 months of the Placement, further funds may need to be raised. As at 31 December 2022, Ikigai's unaudited net assets were GBP1,414,928 and its cash at bank was GBP1,441,043.
Russia/Ukraine
The Company has not been directly impacted by the current war in Ukraine nor by the sanctions imposed on the Russian Federation but may face inflationary pressure as a result of the worldwide impact on global economies.
DIRECTORS
The directors of the Company during the period and for the period to the date these financial statements were signed were as follows:
Mr Ashley Charles Paxton
Mrs Meriel Catherine Lenfestey
Mr Nicholas Harris Bryan-Brown
UNAUDITED STATUS
These interim financial statements are not audited.
DIRECTORS' RESPONSIBILITIES
FOR THE SIX MONTH PERIOD FROM 1 JULY 2022 TO 31 DECEMBER 2022
The directors are responsible for preparing financial statements for each financial period which give a true and fair view, in accordance with the applicable Guernsey law and International Financial Reporting Standards ("IFRS") of the state of affairs of the Company and of the profit or loss of the Company for that period.
In preparing these financial statements, the directors are required to:
Hot Features
Premium
i) select suitable accounting policies and then apply them
consistently;
ii) make judgements and accounting estimates that are reasonable
and prudent;
iii) state whether applicable IFRS accounting standards have
been followed, subject to any material departures disclosed
and explained in the financial statements; and
iv) prepare the financial statements on the going concern basis
unless it is inappropriate to presume that the Company
will continue in business.
The directors confirm that they have complied with the above requirements in preparing the financial statements.
The directors are responsible for keeping proper accounting records that disclose with reasonable accuracy at any time the financial position of the Company and enable them to ensure that the financial statements comply with the Companies (Guernsey) Law, 2008. They are also responsible for safeguarding the assets of the Company and hence for taking reasonable steps for the prevention and detection of fraud and other irregularities.
The directors confirm that, to the best of their knowledge:
- The condensed set of financial statements, which have been
prepared in accordance with IFRS, give a true and fair
view of the assets, liabilities, financial position and
loss of the Company
- The interim management report includes a fair review of
the important events and risks required by DTR 4.2.7 R
and a fair review of the material related party transactions
required by DTR 4.2.8 R
APPROVED BY THE BOARD OF DIRECTORS
Nicholas Bryan-Brown Ashley Paxton Meriel Lenfestey Director Director Director
29 March 2023
STATEMENT OF COMPREHENSIVE INCOME
FOR THE SIX MONTH PERIOD FROM 01 JULY 2022 TO 31 DECEMBER 2022
Six months to Six months to
31 December 2022 31 December 2021
Notes GBP GBP GBP GBP
INCOME
Bank interest 5,282 -
5,282 -
EXPENSES
Administration fees 55,524 37,082
Legal and professional
fees 197,153 222,505
Annual registration fees 250 -
Directors' remuneration 69,228 1,384
Insurance 11,499 5,850
Commission fees 6,500 -
Bank charges 795 160
Sundry expenses 2,406 945
343,355 267,926
OPERATING LOSS GBP (338,073) GBP (267,926)
(Loss) / profit on foreign
exchange (1,376) 3
COMPREHENSIVE LOSS FOR THE
PERIOD GBP (339,449) GBP (267,923)
========== ==========
EARNINGS PER SHARE:
Loss per share GBP (0.02) GBP (0.02)
Diluted loss per share GBP (0.02) GBP (0.02)
There were no items of other comprehensive income during the period, accordingly, only a single statement of comprehensive income is presented.
STATEMENT OF FINANCIAL POSITION
AS AT 31 DECEMBER 2022
As at As at
Notes 31 December 2022 30 June 2022
GBP GBP GBP GBP
CURRENT ASSETS
Other current assets 4 15,400 8,376
Cash and cash equivalents 1,441,043 116,157
1,456,443 124,533
CURRENT LIABILITIES
Trade and other payables 5 41,515 143,023
41,515 143,023
NET CURRENT ASSETS / (LIABILITIES) 1,414,928 (18,490)
NET ASSETS / (LIABILITIES) GBP 1,414,928 GBP (18,490)
========== ==========
CAPITAL AND RESERVES
SHARE CAPITAL 7 - -
SHARE PREMIUM 7 2,333,867 561,000
ACCUMULATED LOSSES (918,939) (579,490)
GBP 1,414,928 GBP (18,490)
========== ==========
STATEMENT OF CHANGES IN EQUITY
FOR THE SIX MONTH PERIOD FROM 01 JULY 2022 TO 31 DECEMBER 2022
Share Share Accumulated Total
Capital Premium Losses Equity
Notes GBP GBP GBP GBP
AT 01 JULY 2021 - - - -
Issued shares 7 - 560,000 - 560,000
Loss for the period - - (267,923) (267,923)
AT 31 DECEMBER 2021 - 560,000 (267,923) 292,077
========= ========== ============ ==========
AT 01 JULY 2022 - 561,000 (579,490) (18,490)
Issued shares 7 - 2,090,000 - 2,090,000
Costs attributable
to issue of shares 7 - (317,133) - (317,133)
Loss for the period - - (339,449) (339,449)
AT 31 DECEMBER 2022 - 2,333,867 (918,939) 1,414,928
========= ========== ============ ==========
STATEMENT OF CASH FLOWS
FOR THE SIX MONTH PERIOD FROM 01 JULY 2022 TO 31 DECEMBER 2022
Six months Six months to
to 31 December
31 December 2021
2022
GBP EUR
CASH FLOWS FROM OPERATING
ACTIVITIES
Total comprehensive loss
for the period (339,449) (267,923)
Adjustments for:
Share-based payment charge - 50,000
(Increase) in other current
assets (7,024) (18,050)
(Decrease)/increase in trade
and other payables (101,508) 140,018
NET CASH USED IN OPERATING
ACTIVITIES (447,981) (95,955)
============= ==============
NET CASH USED IN INVESTING
ACTIVITIES - -
============= ==============
CASH FLOWS FROM FINANCING
ACTIVITIES
Net proceeds from issuance
of share capital 1,772,867 510,000
NET CASH GENERATED FROM
FINANCING ACTIVITIES 1,772,867 510,000
============= ==============
NET CHANGE IN CASH AND
CASH EQUIVALENTS 1,324,886 414,045
Cash and cash equivalents
at the beginning of the
period 116,157 -
CASH AND CASH EQUIVALENTS
AT THE OF THE PERIOD 1,441,043 414,045
============= ==============
NOTES TO THE FINANCIAL STATEMENTS
FOR THE SIX MONTH PERIOD FROM 01 JULY 2022 TO 31 DECEMBER 2022
1. General Information
Ikigai Ventures Limited (the "Company") is a private company limited by shares incorporated on 28 May 2021 in Guernsey under the Companies (Guernsey) Law, 2008, as amended and is registered in Guernsey. The address of the Company's registered office is Martello Court, Admiral Park, St Peter Port, Guernsey, GY1 3HB and the Company's registration number is 69265. On 15 September 2022 the company was admitted to the main market for listed securities of the London Stock Exchange under the ticker symbol "IKIV" with shares registered with an ISIN of GG00BPG8J619 and SEDOL of BPG8J61.
Statement of Compliance
These financial statements give a true and fair view, comply with the Companies (Guernsey) Law, 2008, as amended and were prepared in accordance with the International Financial Reporting Standards ("IFRS") which include standards and interpretations approved by the International Accounting Standards Board, including International Accounting Standards ("IAS") and interpretations issued by the International Financial Reporting Interpretations Committee who replaced the Standards Interpretations Committee.
2. Basis of accounting
The financial statements have been prepared under the historical cost convention, modified to include certain items at fair value, and in accordance with International Financial Reporting Standards ("IFRS") which includes standards and interpretations approved by the International Accounting Standards Board.
The functional and presentation currency of these financial statements is Pounds Sterling.
The principal accounting policies are summarised below. They have all been applied consistently throughout the period and to the preceding period.
Significant Accounting Policies
2.1 Financial Instruments
Financial Assets
The Company's financial assets are cash and cash equivalents and other current assets. The classification is determined by management at initial recognition and depends on the purpose for which the financial assets are acquired.
The Company initially recognises receivables issued when the Company becomes a party to the contractual provisions of the instrument. Financial assets are initially recognised at fair value plus transaction costs for all financial assets not carried at fair value through profit or loss.
Receivables are subsequently carried at amortised cost using the effective interest method. Amortised cost is the initial measurement amount adjusted for the amortisation of any differences between the initial and maturity amounts using the effective interest method. Loans and receivables are reviewed for impairment assessment.
Cash and cash equivalents
Cash and cash equivalents includes cash in hand, deposits held at call with banks, other short-term highly liquid investments with original maturities of three months or less any bank overdrafts.
Other current assets
Debtors principally consist of prepayments which are carried at amortised cost.
The Company assesses at each end of the reporting period whether there is objective evidence that a financial asset or group of financial assets is impaired. A financial asset or group of financial assets is impaired and impairment losses are incurred only if there is objective evidence of impairment as a result of one or more events that have occurred after the initial recognition of the asset (a 'loss event') and that loss event (or events) has an impact on the estimated future cash flows of the financial asset or group of financial assets that can be reliably estimated.
The amount of the loss is measured as the difference between the asset's carrying amount and the present value of estimated future cash flows (excluding future credit losses that have not been incurred) discounted at the financial asset's original effective interest rate. The carrying amount of the asset is reduced and the amount of the loss is recognised in profit or loss.
If, in a subsequent period, the amount of the impairment loss decreases and the decrease can be related objectively to an event occurring after the impairment was recognised (such as an improvement in the debtor's credit rating), the reversal of the previously recognised impairment loss is recognised in profit or loss.
Financial assets are derecognised when the rights to receive cash flows from the financial assets have expired or have been transferred and the Group has transferred substantially all risks and rewards of ownership or has not retained control of the financial asset.
Financial Liabilities
All financial liabilities are initially recognised on the trade date when the entity becomes party to the contractual provisions of the instrument.
Financial liabilities which includes trade and other payables and are recognised initially at fair value, net of directly attributable transaction costs. Financial liabilities are subsequently stated at amortised cost, using the effective interest method.
Financial liabilities are classified as current liabilities if payment is due to be settled within one year or less after the end of the reporting period (or in the normal operating cycle of the business, if longer), or the Company does not have an unconditional right to defer settlement of the liability for at least twelve months after the end of the reporting period. Otherwise, these are presented as non-current liabilities.
Financial liabilities are derecognised from the statement of financial position only when the obligations are extinguished either through discharge, cancellation or expiration. The difference between the carrying amount of the financial liability derecognised and the consideration paid or payable is recognised in profit or loss.
2.2 Equity
Share capital represents the nominal value of shares that have been issued.
Equity-settled share-based payment transactions are measured at fair value (excluding the effect of non market-based vesting conditions) at the date of grant. The fair value determined at the grant date of the equity-settled share-based payments is expensed on the date of grant.
Share premium includes any contributions from equity holders over and above the nominal value of shares issued. Any transaction costs associated with the issuance of shares are deducted from share premium.
Retained earnings represent all current period results of operations as reported in the statement of profit or loss, reduced by the amounts of dividends declared.
2.3 Costs and expenses
Cost and expenses are recognised in profit or loss upon utilisation of goods or services or at the date they are incurred. All finance costs are reported in profit or loss on an accrual basis.
2.4 Taxation
The Company is liable to tax at the standard Guernsey rate of 0%.
2.5 Going Concern
The financial statements have been prepared using the going concern basis of accounting as the directors are comfortable that the Company will continue as a going concern for a period of at least 12 months from 31 December 2022.
COVID-19
The directors continue to monitor the repercussions of the COVID-19 pandemic on any potential impact on the future financial performance of the Company. At the date of signing these financial statements, whilst acknowledging that the pandemic is still active, the directors do not believe that this will have a significant financial impact on the Company in the medium to long term which will prevent the Company from continuing to use the going concern basis of accounting.
Russia/Ukraine
The Company has not been directly impacted by the current war in Ukraine nor by the sanctions imposed on the Russian Federation but may face inflationary pressure as a result of the worldwide impact on global economies.
3. Critical Accounting Estimates And Judgements In Applying Accounting Policies
The preparation of financial statements requires the use of accounting estimates which, by definition, will seldom equal the actual results. Management also needs to exercise judgement in applying the Company's accounting policies.
4. Other Current Assets
Six months Six months
to to
31 December
2022 30 June 2022
GBP GBP
Prepayments 15,400 8,376
15,400 8,376
============ =============
5. Trade And Other Payables
Six months Six months
to to
31 December 30 June
2022 2022
GBP GBP
Administration fees 40,747 11,353
Directors' remuneration - 16,451
Legal and professional
fees 393 115,199
Sundry expenses 375 20
41,515 143,023
============ ===========
6. Taxation
The Company is subject to Guernsey income tax at 0%.
7. Share Capital and Share Premium
Number
of ordinary Ordinary
shares shares Share Premium Total
GBP GBP GBP
------------- --------- -------------- ----------
On incorporation (of
GBP1.00 each) 1 1 - 1
Issue share capital (no
par value each) 15,500,000 - 560,000 560,000
Redemption (of GBP1.00
each) (1) (1) - (1)
------------- --------- -------------- ----------
31 December 2021 15,500,000 - 560,000 560,000
Issue share capital (no
par value each) 1,000,000 - 1,000 1,000
------------- --------- -------------- ----------
30 June 2022 16,500,000 - 561,000 561,000
Issue share capital (no
par value each) 4,180,000 - 2,090,000 2,090,000
Costs attributable to
issue of shares - - (317,133) (317,133)
31 December 2022 20,680,000 - 2,333,867 2,333,867
------------- --------- -------------- ----------
On incorporation, the Company issued 1 ordinary Subscriber Share of GBP1 at par of GBP1. On 29 July 2021, it was resolved to re-designate the sole ordinary share of GBP1 par value issued to Tanglin Capital Limited upon the formation of the Company as a redeemable share, and to redeem the Subscriber Share for GBP1.
On 29 July 2021, Tanglin Capital Limited invested GBP10,000 into the Company as cash consideration for 10,000,000 ordinary shares of no par value at a price of GBP0.001 per share.
On 20 August 2021 and 8 September 2021, the Company issued 3,000,000 and 2,000,000 Ordinary Shares of no par value at a price of GBP0.10 per share in connection with the pre-IPO fundraising, raising a total of GBP500,000.
On 20 August 2021 the Company issued Strand Hanson Limited GBP50,000 in equity as an initiation fee which equates to 500,000 ordinary Shares of no par value at a price of GBP0.10 per share. The Company also agreed, on admission, to issue a Warrant to Strand Hanson Limited to subscribe at any time during the three years following the date of issue of the Warrant for an aggregate number of shares equal to one per cent of the enlarged issued share capital of the Company. The Warrant can be freely assigned by Strand Hanson Limited to any subsidiary or associated company, shareholders or employees.
On 05 April 2022 Nicholas Harris Bryan-Brown invested GBP1,000 into the Company as cash consideration for 1,000,000 ordinary shares of no par value at a price of GBP0.001 per share.
On 15 September 2022 and on admission to the main market for listed securities of the London Stock Exchange, the Company issued 4,180,000 Ordinary Shares of no par value respectively at a price of GBP0.50 each, raising a total of GBP2,090,000.
During the period, the Directors allocated GBP317,133 of costs directly attributable to the issue of shares against Share Premium.
8. Earnings Per Ordinary Share
Period
ended
31 December
2022
GBP
Weighted
average Per-share
of number amount
Earnings of shares GBP
Earning attributable
to Shareholders (339,449) 18,930,761 (0.02)
========== ============ ==========
Basic earnings per Ordinary Share is calculated by dividing the earnings attributable to Shareholders by the weighted average number of Ordinary Shares outstanding during the period.
Diluted earnings per share is calculated by adjusting the weighted average number of Ordinary Shares outstanding to assume conversion of all dilutive potential Ordinary Shares. As at 31 December 2022 (and in accordance with the Warrant issued to Strand Hanson on 20 August 2021 as disclosed in note 7), there were 206,800 warrants outstanding which represented 1% of the number of Ordinary Shares in issue. The fully diluted loss per share attributable to Shareholders (assuming conversion of all dilutive potential Ordinary Shares) as at 31 December 2022 was GBP0.02.
9. Related Party Transactions
The directors' remuneration for Mr Ashley Charles Paxton, Mrs Meriel Catherine Lenfestey and Mr Nicholas Bryan-Brown of the period was GBP12,500 and GBP12,500 and GBP44,228 respectively.
Mr Nicholas Bryan-Brown and Mr Andrew Roberto Mankiewicz OBE have also received GBP5,658 and GBP20,831 respectively as reimbursement of travel and meeting expenses and legal and professional fees paid on behalf of the company during the period to 31 December 2022.
10. Ultimate Controlling Party
The Company is ultimately controlled by Tanglin Capital Limited which is the Parent company, with Tanglin Capital Limited ultimately controlled by Mr Andrew Roberto Mankiewicz OBE.
11. Financial Risk Management
The Company is exposed to a number of risks arising from the financial instruments it holds. The main risks to which the Company is exposed are market risk, credit risk and liquidity risk. The risk management policies employed by the Company to manage these risks are discussed below as follows:
11.1.1 Market risk
Market risk is the risk that changes in market prices such as equity prices, interest rates and foreign exchange rates will affect the Company's income or the value of its holdings of financial instruments. The objective of market risk management is to manage and control market risk exposures within acceptable parameters while optimising the return.
Price risk
The Company is not directly or indirectly exposed to any significant price risk.
Interest rate risk
Interest rate risk is the risk that the fair value of future cash flows of a financial instrument will fluctuate because of changes in market interest rates. Interest rate risk arises on interest-bearing financial instruments recognised in the Statement of Financial Position.
Cash and cash equivalents are interest bearing but not at significant levels.
Currency risk
The Company is exposed to currency risk arising from trade and other payables denominated in United States Dollars. Consequently, the Company is exposed to the risk that the exchange rate of its reporting currency relative to other foreign currencies may change in a manner that has an adverse effect on the fair value or future cash flows of the Company's financial assets or liabilities denominated in currencies other than GBP.
11.1.2 Credit risk
Credit risk is the risk of financial loss to the Company if a counterparty fails to meet its contractual obligations. Credit risk arises from cash and cash equivalents as well as outstanding receivables.
The Company assesses all counterparties for credit risk before contracting with them. The credit risk on cash and cash equivalents is mitigated by entering into transactions with counterparties that are regulated entities subject to prudential supervision, with high credit ratings assigned by international credit rating agencies. Cash and cash equivalents are held with Barclays Bank plc, which at the year end was assigned a credit rating of A by Standard and Poor's rating agency.
The maximum exposure to credit risk is the carrying amount of the financial assets set out below.
Six months Six months
to to
31 December 30 June
2022 2022
GBP GBP
Other current assets 15,400 8,376
Cash and cash equivalents 1,441,043 116,157
Total credit risk exposure 1,456,443 124,533
============ ===========
11.1.3 Liquidity risk
Liquidity risk is the risk that the Company will encounter difficulty in meeting obligations associated with financial liabilities. This risk can arise from mismatches in the timing of cash flows relating to assets and liabilities. The Company receives funding from the shareholders and does not have significant ad hoc expenses to settle. The only significant expense that the Company is exposed to are general operating expenses.
The table below analyses the Company's financial assets and liabilities into the relevant maturity groupings based on the remaining period at the reporting date. The amounts in the table are the contractual undiscounted cash flows. Balances due within 12 months equal their carrying balances, as the impact of discounting is not significant.
As at 31 December 2022 Less 1-12 months More than Total
than 12 months
1 month/on
demand
------------ ------------ ----------- ----------
Assets
Other current assets 15,400 - - 15,400
Cash and cash equivalents 1,441,043 - - 1,441,043
1,456,443 - - 1,456,443
------------ ------------ ----------- ----------
Liabilities
Trade and other payables 41,515 - - 41,515
41,515 - - 41,515
------------ ------------ ----------- ----------
11.2 Capital Risk Management
The capital of the Company is represented by the net assets attributable to the equity shareholder. The Company's objective when managing capital is to safeguard the ability to continue as a going concern in order to provide returns for the shareholder and benefits for other stakeholders.
The Board of Directors and the shareholders monitor capital on the basis of the value of net assets attributable to the equity shareholders.
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
END
IR FLFVIVDIAFIV
(END) Dow Jones Newswires
March 29, 2023 06:43 ET (10:43 GMT)
1 Year Ikigai Ventures Chart |
1 Month Ikigai Ventures Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
